Follow
Philip Almeter
Philip Almeter
Assistant Professor (Adjunct), University of Kentucky College of Pharmacy
Verified email at uky.edu
Title
Cited by
Cited by
Year
Managing the rising costs and high drug expenditures in critical care pharmacy practice
AH Flannery, K Pandya, ME Laine, PJ Almeter, JD Flynn
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (1 …, 2017
252017
ASHP Foundation pharmacy forecast 2019: strategic planning advice for pharmacy departments in hospitals and health systems
LC Vermeulen, ND Eddington, MA Gourdine, J Jorgenson, DA Kvancz, ...
American Journal of Health-System Pharmacy 76 (2), 71-100, 2019
212019
ASHP Foundation Pharmacy Forecast 2018: Strategic planning advice for pharmacy departments in hospitals and health systems
LC Vermeulen, J Kolesar, ML Crismon, AJ Flynn, JG Stevenson, ...
American Journal of Health-System Pharmacy 75 (2), 23-54, 2018
192018
US Food and Drug Administration disruption of generic drug market increases hospital costs
PJ Almeter, JA Labuhn, PE Morris, EA Hessel
Anesthesia & Analgesia 127 (6), 1414-1420, 2018
122018
Supply chain optimization at an academic medical center
J Labuhn, P Almeter, C McLaughlin, P Fields, B Turner
American Journal of Health-System Pharmacy 74 (15), 1184-1190, 2017
122017
FDA approaches in monitoring drug quality, forces impacting the drug quality, and recent alternative strategies to assess quality in the US drug supply
PJ Almeter, JT Isaacs, AN Hunter, BS Henderson, T Platt, BJ Mitchell, ...
Journal of Pharmaceutical Innovation 17 (2), 269-282, 2022
72022
Lack of content uniformity in MMR vaccine
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, RA Lodder
Contact in context 2022, 2022
62022
Variability in content of piperacillin and tazobactam injection
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, RA Lodder
Contact in context 2022, 2022
42022
Potential process control issues with remdesivir
PJ Almeter, JT Isaacs, EE Schuler, RA Lodder
Contact in context 2021, 2021
42021
Spectrometric analysis of dantrolene sodium
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, C McGuire, ...
Contact in context 2023, 2023
32023
Spectrometric analysis of process variations in remifentanil
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, RA Lodder
Contact in context 2022, 2022
32022
Potential process control issues with pemetrexed
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, RA Lodder
Contact in context 2022, 2022
32022
Spectrometric results of process variations in dacarbazine
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, RA Lodder
Contact in context 2022, 2022
32022
Variability in content of hydrocortisone sodium succinate
M Felix, JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, ...
Contact in context 2023, 2023
22023
Quality variations in thyrotropin alfa
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, ...
Contact in context 2023, 2023
22023
Spectral intra-lot and inter-lot variability in carfilzomib
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, H Anwar, ...
Contact in context 2023, 2023
22023
Levothyroxine variations by process analytical technology
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, RA Lodder
Contact in context 2022, 2022
22022
FTNIR spectrometry of micafungin sodium quality
JT Isaacs, PJ Almeter, BS Henderson, AN Hunter, TL Platt, RA Lodder
Contact in context 2022, 2022
12022
Intra-lot and inter-lot variability in cosyntropin
PJ Almeter, JT Isaacs, AN Hunter, BS Henderson, RA Lodder
Contact in context 2021, 2021
12021
Introduction: Strategic planning in challenging times
LC Vermeulen
American Journal of Health-System Pharmacy 75 (2), 24-27, 2018
12018
The system can't perform the operation now. Try again later.
Articles 1–20